Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis. Ann Surg 2017; 265: 481-491.

Published: 26th April 2017

Authors: Pasquali S, Yim G, Vohra R , Mocellin S, Nyanhongo D, Marriott P et al.

Conclusion

There were 33 trials that included 6072 patients. Optimal treatment was neoadjuvant chemoradiotherapy followed by surgery for resectable oesophageal cancer.

Pubmed Link

Your comments

0 Comments